Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Pseudomyxoma Peritonei × Clear all

Status

Completed 9 Recruiting 8 Unknown 7 Active not recruiting 2 Withdrawn 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 380 Neoplasms 266 Carcinoma, Non-Small-Cell Lung 213 Prostatic Neoplasms 206 Colorectal Neoplasms 142 Lung Neoplasms 138 Pancreatic Neoplasms 124 Neoplasm Metastasis 121 Leukemia, Myeloid, Acute 121 Carcinoma, Hepatocellular 110 Multiple Myeloma 106 Lymphoma 103 Head and Neck Neoplasms 93 Melanoma 92 Ovarian Neoplasms 90 Brain Neoplasms 86 Recurrence 82 Leukemia 79 Leukemia, Lymphocytic, Chronic, B-Cell 78 Glioblastoma 75 Colonic Neoplasms 71 Precursor Cell Lymphoblastic Leukemia-Lymphoma 69 Squamous Cell Carcinoma of Head and Neck 68 Lymphoma, Non-Hodgkin 65 Carcinoma, Renal Cell 62 Lymphoma, Follicular 58 Hematologic Neoplasms 57 Lymphoma, Large B-Cell, Diffuse 56 Rectal Neoplasms 54 Stomach Neoplasms 50

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04125225 2020-01-31

What Are the Experiences of Patients With Pseudomyxoma Peritonei?

University of Southampton

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡